1996
DOI: 10.1016/s0002-9610(96)00220-6
|View full text |Cite
|
Sign up to set email alerts
|

The role of anticoagulation in pylephlebitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
138
0
17

Year Published

2005
2005
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 170 publications
(158 citation statements)
references
References 14 publications
3
138
0
17
Order By: Relevance
“…110,111 Outcome of PVT is generally good and mortality primarily is due to underlying cause and less to consequences of portal hypertension. Acute PVT usually has a good prognosis when treated before the occurrence of intestinal infarction.…”
Section: Acute Non-cirrhotic Portal Vein Thrombosismentioning
confidence: 99%
“…110,111 Outcome of PVT is generally good and mortality primarily is due to underlying cause and less to consequences of portal hypertension. Acute PVT usually has a good prognosis when treated before the occurrence of intestinal infarction.…”
Section: Acute Non-cirrhotic Portal Vein Thrombosismentioning
confidence: 99%
“…The diagnosis of pylephlebitis is frequently delayed and requires a high index of suspicion in view of its non-specific clinical presentation and high mortality rate (25%) [1][2][3] . The most common findings include fever, abdominal pain and abnormal liver function tests [4,5] .…”
Section: Discussionmentioning
confidence: 99%
“…However, no underlying etiology may be identified in up to 70% of cases [4] . Blood cultures may be used to guide antibiotic therapy (positive in 23-88% of cases) [1,2] . The most common associated organisms include Bacteroides fragilis, followed by Escherichia coli, Viridans streptococci, Proteus mirabilis and Klebsiella pneumoniae [3,5,11] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nei casi di PVT senza infarto intestinale e a paziente emodinamicamente stabile, la terapia più frequentemente adottata e consigliata è quella che prevede l'uso dell'eparina sia non frazionata sia frazionata, seguita da terapia anticoagulante con warfarin [22][23][24][25][26][27] . La ricanalizzazione del circolo portale in questi casi viene descritta nel 50-80% dei pazienti a fronte di una totale assenza di ricanalizzazione nei pazienti non trattati.…”
Section: Quali Indagini Dovrebbero Essere Fatte Successivamente?unclassified